| 1 | 1-20190 | - | - | - | - | [1] 93 93 |
| 2 | 11C-CSar | - | - | - | - | [2] 93 93, 94 |
| 3 | 13-15mg/kg/d Ursodeoxycholic | - | - | - | - | [1] 93 93 |
| 4 | 18-22mg/kg/d Ursodeoxycholic | - | - | - | - | [1] 93 93 |
| 5 | 3 mg [14C]-A4250 capsule | - | - | - | - | [3] 93 93, 297, 338 |
| 6 | 3-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- | - | - | - | - | [1] 93 93 |
| 7 | 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-oic acid | - | - | - | - | [1] 93 93 |
| 8 | 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid | - | - | - | - | [1] 93 93 |
| 9 | 6 alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747 | - | - | - | - | [1] 93 93 |
| 10 | 6-ECDCA | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 11 | 6-ethylchenodeoxycholic acid | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 12 | 6?-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-747 | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 13 | 6a-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-747 | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 14 | 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 15 | 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 16 | 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (OCA) | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 17 | 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 18 | 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (OCA) | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 19 | 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 20 | 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 21 | 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (OCA) | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 22 | 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 23 | 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (OCA) | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 24 | A11HA02 | - | - | - | - | [1] 93 93 |
| 25 | A4250 | - | - | - | - | [4] 93 93, 296, 297, 338 |
| 26 | Abatacept | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [26] 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
| 27 | Acido Obeticolico | - | - | - | - | [2] 93 93, 94 |
| 28 | Acido ursodessicolico | - | - | - | - | [1] 93 93 |
| 29 | Alkaline Phosphatase | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [4] 46 46, 93, 97, 172 |
| 30 | APD334 | - | - | - | - | [5] 93 93, 96, 97, 98, 269 |
| 31 | ASC42 10 mg | - | - | - | - | [1] 93 93 |
| 32 | ASC42 15 mg | - | - | - | - | [1] 93 93 |
| 33 | ASC42 5 mg | - | - | - | - | [1] 93 93 |
| 34 | Atorvastatin | [1] Atorvastatin Atorvastatin | [3] D00258
D00258
,
D00887
,
D07474
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [18] 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299 |
| 35 | Azathioprine | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [21] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
| 36 | Baricitinib | [1] Baricitinib Baricitinib | [1] D10308
D10308
| [2] JAK1 JAK1, JAK2 💬 | [35] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [13] 41 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325 |
| 37 | BCD-085 | - | - | - | - | [2] 93 93, 271 |
| 38 | Bezafibrat | - | - | - | - | [1] 93 93 |
| 39 | Bezafibrat Genericon retard 400 mg | - | - | - | - | [1] 93 93 |
| 40 | Bezafibrate | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [7] 20 20, 93, 94, 160, 296, 316, 324 |
| 41 | Bezafibrate 100 MG | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 42 | Bezafibrate 200 MG | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 43 | Bezafibrate 200 MG Oral Tablet | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 44 | Bezafibrate 400 MG | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 45 | Bezafibrate IR | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 46 | Bezafibrate SR | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 47 | Bezafibrate, Beza, BZF, Bezalip | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 48 | Bezafibrate, Beza, BZF, Bezalip mono | [1] Bezafibrate Bezafibrate | [1] D01366
D01366
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 49 | Bezalip | - | - | - | - | [3] 93 93, 94, 160 |
| 50 | Bezalip mono | - | - | - | - | [1] 93 93 |
| 51 | Biological: mesenchymal stem cell | - | - | - | - | [1] 93 93 |
| 52 | Budenofalk 3mg | - | - | - | - | [2] 93 93, 97 |
| 53 | BUDESONIDE | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
| 54 | Calcium | [1] Calcium Calcium | - | - | - | [30] 3 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299 |
| 55 | Choline | [1] Choline Choline | [1] D07690
D07690
| - | - | [4] 93 93, 171, 193, 299 |
| 56 | Cilofexor | [1] Cilofexor Cilofexor | - | - | - | [2] 93 93, 94 |
| 57 | CNP-104 | - | - | - | - | [1] 93 93 |
| 58 | CNTO1275 | - | - | - | - | [6] 46 46, 49, 84, 93, 96, 97 |
| 59 | Colchicine | [1] Colchicine Colchicine | [1] D00570
D00570
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [7] 2 2, 42, 46, 56, 93, 210, 266 |
| 60 | Combination antiviral therapy | - | - | - | - | [1] 93 93 |
| 61 | CR845 1.0 mg | - | - | - | - | [1] 93 93 |
| 62 | CRC (A3384) | - | - | - | - | [3] 93 93, 297, 338 |
| 63 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [45] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 |
| 64 | Cyclosporin | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [17] 38 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 |
| 65 | Cyclosporin A | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 46 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 |
| 66 | Denosumab | [1] Denosumab Denosumab | [1] D03684
D03684
| [1] TNFSF11 TNFSF11 💬 | [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [7] 46 46, 50, 93, 95, 96, 274, 299 |
| 67 | E6011 | - | - | - | - | [3] 46 46, 93, 96 |
| 68 | EDP-305 | - | - | - | - | [1] 93 93 |
| 69 | EDP-305 Dose 1 | - | - | - | - | [1] 93 93 |
| 70 | EDP-305 Dose 2 | - | - | - | - | [1] 93 93 |
| 71 | ELAFIBRANOR | [1] Elafibranor Elafibranor | [1] D11208
D11208
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 72 | Elafibranor 120 mg | [1] Elafibranor Elafibranor | [1] D11208
D11208
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 73 | Elafibranor 80 mg | [1] Elafibranor Elafibranor | [1] D11208
D11208
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 74 | Elafibranor 80mg | [1] Elafibranor Elafibranor | [1] D11208
D11208
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 75 | Emtricitabine | [1] Emtricitabine Emtricitabine | [1] D01199
D01199
| - | - | [4] 25 25, 93, 265, 325 |
| 76 | Emtricitabine (FTC)/Tenofovir Disoproxil (TDF) | [2] Emtricitabine Emtricitabine, Tenofovir disoproxil | [2] D01199
D01199
,
D01982
| - | - | [1] 93 93 |
| 77 | Experimental: Seladelpar / MBX-8025 200 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
| 78 | Experimental: Seladelpar / MBX-8025 50 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
| 79 | Ezetimibe | [1] Ezetimibe Ezetimibe | [1] D01966
D01966
| [1] NPC1L1 NPC1L1 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [4] 49 49, 79, 93, 260 |
| 80 | Ezetrol | - | - | - | - | [2] 93 93, 260 |
| 81 | EZT | - | - | - | - | [1] 93 93 |
| 82 | Fenofibrate | [1] Fenofibrate Fenofibrate | [1] D00565
D00565
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [5] 8 8, 79, 93, 94, 265 |
| 83 | Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle) | [1] Fenofibrate Fenofibrate | [1] D00565
D00565
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 84 | FFP104 | - | - | - | - | [2] 93 93, 96 |
| 85 | Fibroscan | - | - | - | - | [2] 93 93, 171 |
| 86 | Fully human monoclonal antibody directed against CXCL10 | - | - | - | - | [1] 93 93 |
| 87 | Fuzhenghuayu | - | - | - | - | [1] 93 93 |
| 88 | GFT505 | - | - | - | - | [1] 93 93 |
| 89 | GKT137831 | - | - | - | - | [2] 85 85, 93 |
| 90 | Gold | [1] Gold Gold | - | - | - | [43] 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318 |
| 91 | GS-9674 | - | - | - | - | [2] 93 93, 94 |
| 92 | GS-9674 100 mg | - | - | - | - | [1] 93 93 |
| 93 | GS-9674 30 mg | - | - | - | - | [1] 93 93 |
| 94 | GSK2330672 | - | - | - | - | [1] 93 93 |
| 95 | GYPP-06 (GKT137831 free base), C10071301-D | - | - | - | - | [1] 93 93 |
| 96 | High protein high fiber diet | - | - | - | - | [2] 93 93, 95 |
| 97 | HTD1801 (BUDCA) | - | - | - | - | [1] 93 93 |
| 98 | ICG | - | - | - | - | [3] 93 93, 94, 235 |
| 99 | INT-747 | - | - | - | - | [1] 93 93 |
| 100 | INT-747, OCA | - | - | - | - | [2] 93 93, 94 |
| 101 | Kaletra | [1] Lopinavir Lopinavir | [1] D01425
D01425
| - | - | [1] 93 93 |
| 102 | Linerixibat | - | - | - | - | [1] 93 93 |
| 103 | Linerixibat (GSK2330672) 40 mg | - | - | - | - | [1] 93 93 |
| 104 | Linerixibat (GSK2330672) 45 mg | - | - | - | - | [1] 93 93 |
| 105 | Linerixibat (GSK2330672) 45mg | - | - | - | - | [1] 93 93 |
| 106 | Liver biopsy | - | - | - | - | [4] 93 93, 171, 231, 240 |
| 107 | LJN452 | - | - | - | - | [1] 93 93 |
| 108 | LJN452, 0,01 mg | - | - | - | - | [1] 93 93 |
| 109 | LJN452, 0,03 mg | - | - | - | - | [1] 93 93 |
| 110 | LJN452, 0,1 mg | - | - | - | - | [1] 93 93 |
| 111 | LUM001 | - | - | - | - | [4] 93 93, 94, 297, 338 |
| 112 | LY3009104 | - | - | - | - | [6] 46 46, 49, 50, 93, 107, 325 |
| 113 | MabThera | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [22] 11 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 |
| 114 | Mabthera® | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [6] 13 13, 35, 43, 44, 46, 93 |
| 115 | Magnesium | [1] Magnesium Magnesium | - | - | - | [19] 3 3, 6, 11, 13, 15, 46, 64, 70, 93, 97, 166, 225, 235, 256, 284, 291, 296, 297, 298 |
| 116 | MBX 8025 | - | - | - | - | [1] 93 93 |
| 117 | MBX-8025 | - | - | - | - | [3] 79 79, 93, 94 |
| 118 | MBX-8025 10 mg Capsule | - | - | - | - | [1] 93 93 |
| 119 | MBX-8025 2 mg Capsule | - | - | - | - | [1] 93 93 |
| 120 | MBX-8025 5 mg Capsule | - | - | - | - | [1] 93 93 |
| 121 | MBX-8025, DSIC | - | - | - | - | [1] 93 93 |
| 122 | MBX-8025, Formulation 2 | - | - | - | - | [1] 93 93 |
| 123 | Methionine | [1] Methionine Methionine | [2] D00019
D00019
,
D04983
| - | - | [7] 34 34, 75, 84, 93, 229, 298, 300 |
| 124 | Methotrexate | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [38] 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
| 125 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
| 126 | Methylprednisolone and azathioprine | [2] Azathioprine Azathioprine, Methylprednisolone | [8] D00238
D00238
,
D00407
,
D00751
,
D00979
,
D03033
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 93 93, 95 |
| 127 | Methylprednisolone and Mycophenolate mofetil | [3] Methylprednisolone Methylprednisolone, Mycophenolate mofetil, Mycophenolic acid | [10] D00407
D00407
,
D00751
,
D00752
,
D00979
,
D05000
,
D05001
,
D05002
,
D05094
,
D05095
,
D05096
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [2] 93 93, 95 |
| 128 | Minodronic acid | [1] Minodronic acid Minodronic acid | - | - | - | [4] 6 6, 46, 93, 95 |
| 129 | MODAFINIL | [1] Modafinil Modafinil | [1] D01832
D01832
| - | - | [4] 6 6, 13, 49, 93 |
| 130 | Moexipril | [1] Moexipril Moexipril | [2] D00623
D00623
,
D08225
| [1] ACE ACE 💬 | [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 93 93 |
| 131 | MXB-8025 | - | - | - | - | [1] 93 93 |
| 132 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
| 133 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] D00752
D00752
,
D05094
,
D05095
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
| 134 | NCA 500mg | - | - | - | - | [1] 93 93 |
| 135 | NGM282 | - | - | - | - | [2] 93 93, 94 |
| 136 | NI-0801 | - | - | - | - | [1] 93 93 |
| 137 | Non-myeloablative Hematopoietic Stem Cell Transplantation | - | - | - | - | [1] 93 93 |
| 138 | Norucholic acid | [1] norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | [2] 93 93, 94 |
| 139 | Norucholic acid (NCA) 500 mg | [1] norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | [1] 93 93 |
| 140 | Obeticholic Acid | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [3] 93 93, 265, 296 |
| 141 | Obeticholic Acid (OCA) | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 142 | Obeticholic Acid 5 MG | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 143 | Obeticholic Acid Tablets | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 144 | OCA (INT-747) | - | - | - | - | [1] 93 93 |
| 145 | OCA, INT-747 | - | - | - | - | [1] 93 93 |
| 146 | Ocaliva | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [2] 93 93, 296 |
| 147 | Ocaliva 10mg | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 148 | Ocaliva 5mg | [1] Obeticholic acid Obeticholic acid | [1] D09360
D09360
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 149 | Olumiant | [1] Baricitinib Baricitinib | [1] D10308
D10308
| [2] JAK1 JAK1, JAK2 💬 | [35] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [4] 46 46, 49, 93, 107 |
| 150 | OP-724 | - | - | - | - | [1] 93 93 |
| 151 | Other: Blood samples | - | - | - | - | [1] 93 93 |
| 152 | Other: Questionnaires | - | - | - | - | [5] 6 6, 13, 41, 93, 96 |
| 153 | Part 1: LJN452 | - | - | - | - | [1] 93 93 |
| 154 | Part 2: LJN452 Dose level 1 | - | - | - | - | [1] 93 93 |
| 155 | Part 2: LJN452 Dose level 2 | - | - | - | - | [1] 93 93 |
| 156 | Pemafibrate | [1] Pemafibrate Pemafibrate | [1] D10711
D10711
| [1] PPARA PPARA 💬 | [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 |
| 157 | Pentoxifylline | [1] Pentoxifylline Pentoxifylline | [1] D00501
D00501
| - | - | [10] 26 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 |
| 158 | PHENYLBUTYRATE | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [12] 2 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338 |
| 159 | Probiotic | - | - | - | - | [7] 2 2, 6, 93, 96, 97, 193, 266 |
| 160 | PYRIDOXINE | [1] Pyridoxine Pyridoxine | [2] D02179
D02179
,
D08454
| - | - | [3] 93 93, 145, 320 |
| 161 | Pyridoxine 10mg | [1] Pyridoxine Pyridoxine | [2] D02179
D02179
,
D08454
| - | - | [1] 93 93 |
| 162 | Pyridoxine 10mg BP | [1] Pyridoxine Pyridoxine | [2] D02179
D02179
,
D08454
| - | - | [1] 93 93 |
| 163 | Questran | [1] Cholestyramine Cholestyramine | - | - | - | [4] 93 93, 254, 297, 338 |
| 164 | Raltegravir | [1] Raltegravir Raltegravir | [1] D06676
D06676
| - | - | [4] 13 13, 26, 93, 265 |
| 165 | RhuDex 100 mg (127 mg RhuDex choline salt) granules | [1] Choline Choline | [1] D07690
D07690
| - | - | [1] 93 93 |
| 166 | RhuDex 25 mg (31.75 mg RhuDex choline salt) granules | [1] Choline Choline | [1] D07690
D07690
| - | - | [1] 93 93 |
| 167 | RhuDex 50 mg (63.5 mg RhuDex choline salt) granules | [1] Choline Choline | [1] D07690
D07690
| - | - | [1] 93 93 |
| 168 | RhuDex choline salt | [1] Choline Choline | [1] D07690
D07690
| - | - | [1] 93 93 |
| 169 | Rifampicin | [1] Rifampicin Rifampicin | [1] D00211
D00211
| - | - | [6] 6 6, 17, 46, 93, 299, 338 |
| 170 | Rifaximin | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [7] 6 6, 65, 93, 96, 97, 99, 296 |
| 171 | Risedronic acid | [1] Risedronic acid Risedronic acid | [3] D00942
D00942
,
D03234
,
D08484
| [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [3] 93 93, 95, 274 |
| 172 | Rituximab | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [49] 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
| 173 | S-adenosyl-L-methionine | [1] Methionine Methionine | [2] D00019
D00019
,
D04983
| - | - | [1] 93 93 |
| 174 | S-adenosyl-methionine (SAMe) capsules | [2] Ademetionine Ademetionine, Methionine | [3] D00019
D00019
,
D04983
,
D07128
| - | - | [1] 93 93 |
| 175 | SAMe | [1] Ademetionine Ademetionine | [1] D07128
D07128
| - | - | [1] 93 93 |
| 176 | Saroglitazar | [1] Saroglitazar Saroglitazar | - | - | - | [1] 93 93 |
| 177 | Saroglitazar Magnesium 1 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 |
| 178 | Saroglitazar Magnesium 2 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 |
| 179 | Saroglitazar magnesium 4 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 |
| 180 | SELADELPAR | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [2] 93 93, 94 |
| 181 | Seladelpar 10 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
| 182 | Seladelpar 10 mg Capsule | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
| 183 | Seladelpar 10 mg or less | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
| 184 | Seladelpar 5 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
| 185 | Seladelpar 5 mg Capsule | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
| 186 | Seladelpar 5-10 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
| 187 | SETANAXIB | - | - | - | - | [1] 93 93 |
| 188 | Sortis | - | - | - | - | [1] 93 93 |
| 189 | Sortis 10 mg | - | - | - | - | [1] 93 93 |
| 190 | Sublimated mare milk | - | - | - | - | [1] 93 93 |
| 191 | TAUROURSODEOXYCHOLIC ACID | [1] Tauroursodeoxycholic acid Tauroursodeoxycholic acid | [1] D11836
D11836
| - | - | [4] 2 2, 13, 93, 299 |
| 192 | Tauroursodeoxycholic Acid Capsules | [1] Tauroursodeoxycholic acid Tauroursodeoxycholic acid | [1] D11836
D11836
| - | - | [1] 93 93 |
| 193 | Tenofovir | [1] Tenofovir disoproxil Tenofovir disoproxil | [1] D01982
D01982
| - | - | [6] 2 2, 13, 25, 93, 265, 325 |
| 194 | Tenofovir disoproxil | [1] Tenofovir disoproxil Tenofovir disoproxil | [1] D01982
D01982
| - | - | [2] 93 93, 265 |
| 195 | Tetrathiomolybdate | [1] Tetrathiomolybdate Tetrathiomolybdate | - | - | - | [3] 85 85, 93, 171 |
| 196 | Thiamine | [1] Thiamine Thiamine | [1] D08580
D08580
| - | - | [4] 8 8, 13, 93, 265 |
| 197 | Tiamin DAK | - | - | - | - | [1] 93 93 |
| 198 | Tiamin SAD | - | - | - | - | [1] 93 93 |
| 199 | Tigecycline | [1] Tigecycline Tigecycline | [1] D01079
D01079
| - | - | [1] 93 93 |
| 200 | TQA3526 | - | - | - | - | [1] 93 93 |
| 201 | Tropifexor | [1] Tropifexor Tropifexor | [1] D11548
D11548
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 202 | Truvada and Kaletra | [1] Lopinavir Lopinavir | [1] D01425
D01425
| - | - | [1] 93 93 |
| 203 | UDCA | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [6] 46 46, 67, 93, 94, 97, 296 |
| 204 | UDCA (Ursodeoxycholic acid) | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 205 | Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation | - | - | - | - | [2] 93 93, 296 |
| 206 | Ursodeoxycholic acid | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [9] 6 6, 46, 67, 84, 93, 94, 95, 96, 97 |
| 207 | Ursodeoxycholic Acid (URSO) | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 208 | Ursodeoxycholic Acid 300mg capsule | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 209 | Ursodeoxycholic Acid 300mg tablet | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 210 | Ursodeoxycholic Acid Capsules | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 211 | Ursodeoxycholic acid combination of immunosuppressive agents | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [2] 93 93, 95 |
| 212 | Ursodeoxycholic acid combined with total glucosides of paeony | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 213 | Ursodeoxycholic acid only | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 214 | Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) | [2] Methylprednisolone Methylprednisolone, Ursodeoxycholic acid | [7] D00407
D00407
,
D00734
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [2] NR1H4 NR1H4, NR3C1 💬 | [2] Bile secretion Bile secretion, Neuroactive ligand-receptor interaction 💬 | [1] 93 93 |
| 215 | Ursodeoxycholsäure | - | - | - | - | [1] 93 93 |
| 216 | Ursodiol | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [6] 8 8, 20, 93, 97, 234, 299 |
| 217 | Ursofalk | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [4] 93 93, 94, 96, 97 |
| 218 | Ursofalk® 500 mg film-coated tablets | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 219 | Ursofalk® 500 mg Filmtabletten | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 220 | Ursofalk® capsules | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] D00734
D00734
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 93 93 |
| 221 | Ustekinumab | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [17] 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 |
| 222 | Ustekinumab 180 mg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 93 93 |
| 223 | Ustekinumab 45 mg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 93 93 |
| 224 | Ustekinumab 90 mg | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [4] 49 49, 50, 93, 96 |
| 225 | Vitamin D | [1] Vitamin D Vitamin D | - | - | - | [24] 3 3, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 |
| 226 | Volixibat | [1] Volixibat Volixibat | [1] D11007
D11007
| - | - | [2] 93 93, 94 |
| 227 | Zoledronic acid | [1] Zoledronic acid Zoledronic acid | [4] D01968
D01968
,
D06378
,
D06379
,
D08689
| [1] FDPS FDPS 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [12] 5 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333 |